Ethnicity and clinical outcome for advanced epithelial ovarian cancer patients treated by standard cisplatin/paclitaxel chemotherapy: A combined analysis of gynecologic oncology group clinical trials

被引:2
|
作者
Farley, J. H.
Tian, C.
Rose, G. S.
Brown, C. L.
Risinger, J. I.
Maxwell, G. L.
机构
[1] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[2] Gynecol Oncol Grp, Rosewell Pk, NY USA
[3] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[5] Curtis & Elizabeth Anderson Canc Inst, Savannah, GA USA
关键词
D O I
10.1200/jco.2008.26.15_suppl.5573
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5573
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Race Does Not Impact Outcome for Advanced Ovarian Cancer Patients Treated With Cisplatin/Paclitaxel An Analysis of Gynecologic Oncology Group Trials
    Farley, John H.
    Tian, Chunqiao
    Rose, G. Scott
    Brown, Carol L.
    Birrer, Michael
    Maxwell, G. Larry
    CANCER, 2009, 115 (18) : 4210 - 4217
  • [2] Association of Single Nucleotide Polymorphisms in 5 Loci of BRCA1 with Clinical Outcome in Epithelial Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study
    Lesnock, J.
    Darcy, K.
    Tian, C.
    DeLoia, J.
    Armstrong, D.
    Birrer, M.
    Gallion, H.
    Krivak, T.
    GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 394 - 395
  • [3] Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancer
    Poole, CJ
    Perren, T
    Burton, A
    Jordan, SD
    Jenkins, AH
    Mould, JJ
    Spooner, DA
    Luesley, D
    Chan, KK
    Sturman, S
    Earl, HM
    ANNALS OF ONCOLOGY, 2000, 11 (12) : 1603 - 1608
  • [4] The clinical-pathologic factors relevant to intraperitoneal chemotherapy in ovarian cancer: An analysis of two Gynecologic Oncology Group trials
    Tewari, D.
    Chunqiao, T.
    Armstrong, D. K.
    Markman, M.
    Herzog, T. J.
    Monk, B. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] The prognostic value of ERCC1 expression in patients with stage III epithelial ovarian cancer treated with cisplatin and paclitaxel: A Gynecologic Oncology Group study
    Rubatt, J.
    Darcy, K.
    Tian, C.
    Muggia, F.
    Dhir, R.
    Armstrong, D.
    Niedernhofer, L.
    Krivak, T.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S160 - S160
  • [6] Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery
    Muraji, Miho
    Sudo, Tamotsu
    Iwasaki, Shin-ichi
    Ueno, Sayaka
    Wakahashi, Senn
    Yamaguchi, Satoshi
    Fujiwara, Kiyoshi
    Nishimura, Ryuichiro
    GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 531 - 534
  • [7] First clinical experiences with intraperitoneal cisplatin-paclitaxel chemotherapy in epithelial ovarian cancer
    Weissenboeck, E.
    Zeimet, A. G.
    Marth, C.
    Braun, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 525 - 525
  • [8] Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study
    DuPont, Nefertiti C.
    Enserro, Danielle
    Brady, Mark F.
    Moxley, Katherine
    Walker, Joan L.
    Cosgrove, Casey
    Bixel, Kristin
    Tewari, Krishnansu S.
    Thaker, Premal
    Hendrickson, Andrea E. Wahner
    Rubin, Stephen
    Fujiwara, Keiichi
    Casey, A. Catherine
    Soper, John
    Burger, Robert A.
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2022, 164 (02) : 398 - 405
  • [9] A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology Group study
    Armstrong, Deborah K.
    Bookman, Michael A.
    McGuire, William
    Bristow, Robert E.
    Schilder, Jeanne M.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 667 - 671
  • [10] BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study
    Lesnock, J. L.
    Darcy, K. M.
    Tian, C.
    DeLoia, J. A.
    Thrall, M. M.
    Zahn, C.
    Armstrong, D. K.
    Birrer, M. J.
    Krivak, T. C.
    BRITISH JOURNAL OF CANCER, 2013, 108 (06) : 1231 - 1237